The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 343:1113-1114 October 12, 2000 Number 15
NextNext

Asthma, Steroids, and Growth

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by The Childhood Asthma Management Program Research Group
-Related Article
 by Agertoft, L.
-PubMed Citation
Long-term administration of systemic corticosteroids is a cause of impaired growth.1 Trials comparing inhaled corticosteroid preparations with other treatment regimens in nearly 600 children with asthma found that inhaled beclomethasone had greater therapeutic effect than did other regimens.2,3,4,5 In the studies, each of which lasted about one year, children treated with inhaled corticosteroids had less growth in height (1 to 1.6 cm [23 to 27 percent] less) than those assigned to other treatments. The mechanisms by which this delay in growth occurs are unknown. If inhaled corticosteroids are not discontinued, does growth suppression continue, so that children with asthma who . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.